Summary
Elevance Health, Inc. (formerly Anthem, Inc.) issued this 8-K filing on June 4, 2021, to disclose information that will be discussed by company officers during investor meetings over the coming weeks. The primary focus of the disclosure is to reaffirm the company's financial guidance for the full year 2021. Management expects net income to be greater than $24.05 per share, which includes approximately $1.05 per share in unfavorable items. Excluding these anticipated unfavorable items, Elevance Health continues to project adjusted net income to exceed $25.10 per share for the fiscal year 2021. This guidance is based on information previously reported in the company's first quarter 2021 earnings release and does not incorporate any new adjustment items beyond those already disclosed. The company also included standard forward-looking statement disclaimers, highlighting various risks and uncertainties that could materially impact actual results.
Key Highlights
- 1Reaffirmation of Full Year 2021 Net Income Guidance: Greater than $24.05 per share.
- 2Projected Adjusted Net Income: Expected to be greater than $25.10 per share, excluding unfavorable items.
- 3Inclusion of Unfavorable Items: Guidance incorporates approximately $1.05 per share of net unfavorable items.
- 4Guidance Basis: Based on information from the Q1 2021 earnings release; no new adjustment items beyond prior disclosures.
- 5Investor Meetings Planned: Company officers will engage with investors over several weeks to discuss guidance and business.
- 6Standard Forward-Looking Statements: Filing includes customary legal disclaimers regarding risks and uncertainties.
- 7Company Name Change Mention: Implicitly refers to the company as Elevance Health, Inc., though the filing retains reference to Anthem, Inc. in the text.